Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, has been informed that Mr Johan Goossens, Chairman, purchased 100,000 ordinary shares of Euro 0.10 ('Ordinary Shares') at a price range between €1.19 and €1.24 on Friday 5 April and on Monday 8 April 2013.
Following this purchase, Mr Johan Goossens is beneficially interested in 1,447,059 ordinary shares, representing approximately 15.7% of the Group's issued share capital.
Enquiries:
| Cryo-Save Group | + 31 (0) 575 509 100 |
| Arnoud van Tulder, Chief Executive Officer |
About Cryo-Save (www.cryo-save.com/group)
Cryo-Save, the leading international family stem cell bank, stores more than 225,000 samples from umbilical cord blood and cord tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Cryo-Save has cryopreserved samples from over 70 countries on six continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India and South Africa.
